• Přeskočit na obsah
  • Přeskočit na menu

  • Home
  • Vyvanse® Important Safety Information
  • Full Prescribing Information
  • Medication Guide
  • For Health Care Professionals
  • Vyvanse for Adults
  • "vi-vans"

Vyvanse

Vyvanse ® Information about Kids with ADHD Aged 6 to 12

  • About Vyvanse for Children
    • Vyvanse ADHD Symptom Control
    • Vyvanse Side Effects and Tolerability
    • Vyvanse Dosing Information
    • Starting Vyvanse
  • ADHD in Children
  • ADHD and the Family
  • Resources and Tools
    • ADHD Frequently Asked Questions
    • Online ADHD Resources
    • Vyvanse SHINE
  • Savings Offer (Restrictions may apply)

Resources and Tools

Learning about ADHD in children can be an overwhelming process. Here are some tips and tools designed to help.

AWARE
Brochure

An educational guide for parents about proper stimulant use

  • View the Brochure

Tips
for Parents

Get tips designed
to help
day to day

  • View the Tips
    for Parents

Symptom Discussion Guide

A guide to talk to your child's doctor about ADHD

  • View the
    Discussion Guide

Teacher Discussion Guide

Get helpful feedback from your child’s teachers

  • View the
    Discussion Guide

Get Adobe Reader To view and print these documents, you will need Adobe Reader

Next: ADHD Frequently Asked Questions



Vyvanse® is a registered trademark of Shire LLC. Vyvanse Full Prescribing Information and Medication Guide
ADDERALL XR® is a registered trademark of Shire LLC. ADDERALL XR Full Prescribing Information and Medication Guide
Daytrana® is a registered trademark of Shire Pharmaceuticals Ireland Limited. Daytrana Full Prescribing Information and Medication Guide
INTUNIV™ is a trademark of Shire LLC. INTUNIV Patient Information
All other product names are the trademarks of their respective companies.

Indication

Vyvanse is a prescription medicine for the treatment of ADHD. Efficacy based on two controlled trials in children aged 6 to 12 and two controlled trials in adults. Vyvanse should be used as part of a total treatment program that may include counseling or other therapies.

Important Safety Information

Vyvanse is a stimulant medicine. Abuse of stimulants may lead to dependence. Misuse of stimulants may cause sudden death and serious cardiovascular adverse events. These events have also been reported rarely with stimulant use.

Tell the doctor about any heart conditions, including structural abnormalities, that you, your child, or a family member, may have. Inform the doctor immediately if you or your child develops symptoms that suggest heart problems, such as chest pain or fainting.

Vyvanse should not be taken if you or your child has:
  • advanced disease of the blood vessels (arteriosclerosis);
  • symptomatic heart disease;
  • moderate to severe high blood pressure;
  • overactive thyroid gland (hyperthyroidism);
  • known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine);
  • glaucoma;
  • a history of problems with alcohol or drugs;
  • agitated states;
  • taken a monoamine oxidase inhibitor (MAOI) within the last 14 days.
Tell the doctor before taking Vyvanse if you or your child:
  • is being treated for or has symptoms of depression (sadness, worthlessness, or hopelessness) or bipolar disorder;
  • has abnormal thoughts or visions, hears abnormal sounds, or has been diagnosed with psychosis;
  • has had seizures or abnormal EEGs;
  • has or has had high blood pressure;
  • exhibits aggressive behavior or hostility.

Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse.

Talk to your health care provider if your child experiences slowing of growth (height and weight). Children should have their height and weight checked periodically while taking Vyvanse. Your health care provider may stop Vyvanse treatment if a problem is found during these check-ups.

The most common side effects reported in studies of Vyvanse were:
  • upper belly pain,
  • dry mouth,
  • weight loss,
  • irritability,
  • vomiting,
  • nausea,
  • dizziness,
  • trouble sleeping,
  • decreased appetite.

Aggression, new abnormal thoughts/behaviors, mania, growth suppression, worsening of motion or verbal tics, and Tourette’s syndrome have been associated with use of drugs of this type. Tell the doctor if you or your child has blurred vision while taking Vyvanse.

For additional safety information, please see Full Prescribing Information and Medication Guide, including WARNING about Potential for Abuse, and discuss with your doctor.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You are about to leave vyvansesavingscard.com. Please be advised that Shire Pharmaceuticals has no control over the content or presentation of the site you are about to view.
BackContinue

Shire

©2010 Shire US Inc., Wayne, PA 19087-5637. 1-800-828-2088. All rights reserved. Vyvanse® is a registered trademark of Shire LLC. VYV-01697 08/10

This site is strictly intended for US residents and is governed solely by US laws and government regulations. Please see our online privacy policy for more information. While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

  • Contact Us
  • Privacy Policy
  • Unsubscribe
  • Full Prescribing Information
  • Medication Guide
  • Site Map